From the four options I spoke of earlier in the week, I’ve gone all in with Lloyds (option 1) fully taking up my offered allotment of 1,037 shares at £0.37 a share. The rights issue gave me a reduction on current market value of about £0.16 per share or 30%, so I can’t really complain, despite doing my darnedest in my most recent post. Our total holding of Lloyds has now risen to 1,...

Personally, I’ve always considered trading shares a very intimate process. I would do my homework, I would look at the market and I would decide, initially my entry point, and down the track, my exit point for any given equity. The timings were mine, the mistakes – of which there have been many – were mine, and even the odd windfall was mine. It was done to my schedule. I had no ...

So I’ve been talking about it for long enough but last Friday I put my money where my mouth was and topped up on some Renesola, adding another 692 shares to our holding at £1.23488 a share for a total consideration of £854.54. Renesola has been on our radar again since it visited the 150 pence mark in late September where it traded within a range for a fortnight or so before continuing its...

Another three-figure write-off day for the FTSE and again our portfolio is adrift atop a sea of red, but its not all bad news. We’ve taken the opportunity to sell off a few of our Eros International shares. We first got on board with Eros International – a Bollywood film producer and distributor – in early May of this year, purchasing 533 shares at £1.05 a share for a total outl...

We’ve been stockpiling a little cash of late at Investor Trader – taking the top off one or two nicely performing investments – and today we blew the lot! Again we’ve sent our money east to the Chinese, this time to their agricultural sector purchasing some 254 shares of Asian Citrus (ACHC.L) at £4.27 per share for a total outlay before costs of £1,085. The reasons in bri...

A while back (June in fact) I wrote extolling the virtues of a company by the name of Cosalt and promptly put my money where my mouth was, purchasing 916 shares at £0.5437 for a total outlay of £498.03. I’d read a little good press, the company seemed to have had it’s problems in the recent past, but was moving in the right direction and with prices nearing five quid back in ‘0...

Following the sale of our Lyxor EFT India holdings we’ve moved the cash a little further east taking up another tranche of West China Cement (WCC.L). Although West China Cement has already run up from £1.70 to £2.55 since our first uptake a few weeks back, we still think there’s plenty o’ good times ahead with West China Cement and we were happy to jump in with today’s pu...

So we’ve gone and upped our stake in China Biodiesel after making 55% gains (from 6.6 pence to 10.25 pence) since our small, test purchase this time last week. I call it a test purchase, but in reality I just lacked the cojones to have a real punt. Anyway, I digress. We sold out of Climate Exchange and smacked the total consideration (£687.50) into China Biodiesel, purchasing a further 6,83...

And the last of our three purchases for the day yesterday was Synergy Health, where we bit the bullet and went big (for us) purchasing 82 shares at £5.0800 for a total outlay of £416.56 Why? An oversold equity with a healthy order book, long term contracts and an X factor in the potential of its Chinese operations. You can read all about it in yesterday’s post where we added it to the Inve...

So we’ve taken the plunge with some concrete boots, but don’t panic, that’s West China Cement on our feet! Yesterday we purchased 153 shares of West China Cement at £1.7050 a share for another huge outlay (don’t trip on the sarcasm) of £260.87. The reasons? Well I won’t bore you again, but check out this one I made earlier. So another small outlay on a Chinese AIM S...